Together, these data suggest that down modulation of protumor M2 macrophages by αvβ3-MI3-PD NP decreased (P<0.05) tumor activity in both an ER+ a triple negative breast cancer model two mouse genetic backgrounds without any hematological toxicity. The gene discussed is ESR1; the disease is neoplasm.